  The COVID-19 pandemic has initiated a global health emergency, with an
exigent need for effective cure. Progressively, drug repurposing is emerging as
a promising solution as it saves the time, cost and labor. However, the number
of drug candidates that have been identified as being repurposed for the
treatment of COVID-19 are still insufficient, so more effective and thorough
drug repurposing strategies are required. In this study, we joint the molecular
docking with machine learning regression approaches to find some prospective
therapeutic candidates for COVID-19 treatment. We screened the 5903 approved
drugs for their inhibition by targeting the main protease 3CL of SARS-CoV-2,
which is responsible to replicate the virus. Molecular docking is used to
calculate the binding affinities of these drugs to the main protease 3CL. We
employed several machine learning regression approaches for QSAR modeling to
find out some potential drugs with high binding affinity. Out outcomes
demonstrated that the Decision Tree Regression (DTR) model with best scores of
R2 and RMSE, is the most suitable model for drug repurposing. We shortlisted
six favorable drugs and examined their physiochemical and pharmacokinetic
properties of these top-ranked selected drugs and their best binding
interaction for specific target protease 3CLpro. Our study provides an
efficient framework for drug repurposing against COVID-19, and establishes the
potential of combining molecular docking with machine learning regression
approaches to accelerate the identification of potential therapeutic
candidates. Our findings contribute to the larger goal of finding effective
cures for COVID-19, which is an acute global health challenge.
